Thus, it will be necessary to study cellular origins of PLCβ1 expression in gliomas to determine if different levels of PLCβ1 expression actually originate from oligodendrocytes, astrocytes, or even possibly mesenchymal cells versus normal and abnormal neuroprogenitor cells, or neurons. Here, PLCB1 is linked to central nervous system cancer.